E Point Perfect – Interesting and beneficial content
Law \ Legal

Insight on Request for Supreme Court Review of Anti-Kickback Statute’s Scope


I recently provided insight for a Law360 article outlining Pfizer’s request to have the Supreme Court weigh in on the scope of the Anti-Kickback Statute (AKS).

Pfizer is challenging decisions by the Second Circuit and a federal district court, claiming that the rulings provide a “staggeringly overbroad” interpretation of the AKS that limits how companies can help patients pay for drugs.

I also noted that there’s no circuit split for the Supreme Court to resolve, adding that it’s unlikely the justices will “determine that the Second Circuit departed so significantly from the accepted and usual course of judicial proceedings” that they should get involved.

The full article, “Pfizer Gives Justices Rare Shot At Scrutinizing Kickback Ban,” was published by Law360 on October 14 and is available online. To read more about this case, specifically the Second Circuit decision, read our Inside the False Claims blog post here.


Source link

Related posts

Celebrity Estate Planning: Misfires of the Rich and Famous

Recovering Field Overhead Expenses – LexBlog

A Judge Just Risked Penn State’s Trademarks — And Those of Other Schools

Join us for a discussion about INTERPOL Abuse on February 3

Damage Claim For Denying Lincoln Memorial Religious Demonstration Permit Dismissed

Food Safety Month begins with risk-reducing home handling tips for poultry